Frequent Emergence of Resistance Mutations Following Complex Intra-Host Genomic Dynamics in SARS-CoV-2 Patients Receiving Sotrovimab
Authors:
- 18 July 2023
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 67 (7) , e0026623
Abstract
The emergence of the Omicron variant of SARS-CoV-2 represented a challenge to the treatment of COVID-19 using monoclonal antibodies. Only Sotrovimab maintained partial activity, allowing it to be used in high-risk patients infected with the Omicron variant.Keywords
All Related Versions
Funding Information
- MEC | Instituto de Salud Carlos III (PI21/01823)
This publication has 15 references indexed in Scilit:
- Sotrovimab Resistance and Viral Persistence After Treatment of Immunocompromised Patients Infected With the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron VariantClinical Infectious Diseases, 2022
- Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimabClinical Microbiology and Infection, 2022
- Coronavirus Resistance Database (CoV-RDB): SARS-CoV-2 susceptibility to monoclonal antibodies, convalescent plasma, and plasma from vaccinated personsPLOS ONE, 2022
- Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab UseNew England Journal of Medicine, 2022
- Systematic Genomic and Clinical Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfections and Recurrences Involving the Same StrainEmerging Infectious Diseases, 2022
- Glycan Masking of Epitopes in the NTD and RBD of the Spike Protein Elicits Broadly Neutralizing Antibodies Against SARS-CoV-2 VariantsFrontiers in Immunology, 2021
- Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerabilityImmunity, 2021
- The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and in vivo activity against SARS-CoV-2bioRxiv, 2021
- StatPearls2021
- Compartmentalized Replication of SARS-Cov-2 in Upper vs. Lower Respiratory Tract Assessed by Whole Genome Quasispecies AnalysisMicroorganisms, 2020